Please login to the form below

Not currently logged in
Email:
Password:

Recipharm Italy appoints new general manager

Dr Giorgio Bruno has worked with companies such as AstraZeneca and Corden

Recipharm Giorgio BrunoCMO firm Recipharm has appointed Dr Giorgio Bruno as its new general manager of Recipharm Italia.

In this role, he will serve as CEO for all of Recipharm's Italian operating companies which employ some 257 people at three sites and have revenues of €57m.

Dr Bruno has long established senior management experience from within the pharmaceutical industry, especially in the area of manufacturing. 

He has worked in both Italian and multinational pharma companies covering a wide range of disciplines. 

In particular he has had responsibility for quality and manufacturing at such companies including Parke Davis, AstraZeneca and Corden Pharma. 

He holds a PhD in Pharmaceutical Chemistry and Technology from the University of Milan. 

Thomas Eldered, CEO of Recipharm, said: “I am very pleased to welcome Dr Bruno to the Recipharm team. We are very fortunate to have been able to attract such a competent and highly experienced manager to this important position and I look forward to him bringing his expertise to bear across our Italian operations for which he is now responsible.” 

24th April 2015

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

Good design saves lives
Good design and creative thinking are essential if we are to improve on existing problems in new ways, which is why design and creativity within healthcare is vital. Health is...
Why you must understand the pricing of patient recruitment companies
Recruiting a diverse range of patients and engaging with them for your clinical trial isn’t an easy task, which means you might turn to patient recruitment companies, like us, who...
wearable health tech
A cultural shift in clinical research
Research organisations across the board are experimenting with new technologies...

Infographics